Bonus BioGroup Ltd. (TLV:BONS)
Israel · Delayed Price · Currency is ILS · Price in ILA 35.00
+3.10 (9.72%)
Jul 1, 2026, 2:19 PM IDT
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 372.64 million as of July 1, 2026. Its market cap has increased by 22.71% in one year.
Market Cap
372.64M
Enterprise Value
381.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
35.00
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 372.64M, an increase of 2,914.21%. That is a compound annual growth rate of 27.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 377.31M | 28.71% |
| Dec 31, 2025 | 293.15M | 110.92% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 290.02M |
| Matricelf | 83.32M |
| Clal Biotechnology Industries | 39.84M |
| BioLineRx | 39.31M |
| BioLight Life Sciences | 34.85M |
| Can-Fite BioPharma | 19.24M |
| Purple Biotech | 18.65M |
| XTL Biopharmaceuticals | 17.03M |